IACH News of the week
IACH News of the Week, curated by Dr Edwin Uriel Suárez , is a weekly summary of the latest advancements and discoveries in the field of hematology compiled in an easy-to-digest format. It highlights research breakthroughs, clinical trial results, interesting case studies, and important health advisories – all within the last week. This is a valuable tool for medical professionals with limited time to stay up-to-date on the ever-evolving world of hematology.
- Multiple Myeloma: 2026 Update on Diagnosis, Risk-Stratification and Management (Review - ANNUAL CLINICAL UPDATES IN HEMATOLOGICAL MALIGNANCIES from American Journal of Hematology).
- Redefining plasma cell leukaemia (Personal View from The Lancet Haematology journal)
- How I prevent infections in adults receiving bispecific antibody therapies for advanced B-cell malignancies (Review - How I Treat from Blood journal)
- American Society of Hematology 2026 Guidelines for Immune Thrombocytopenia (ITP): Initial and Second-Line Therapy in Adults with Primary ITP
- Guideline on the emergency management of critical bleeding in patients with immune thrombocytopenia
- Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial
- The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline
- Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial
- Myeloproliferative Neoplasms (Review Article)
- Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma (Phase 3 clinical trial)
- YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer. A Randomized Clinical Trial
- Polatuzumab Vedotin Plus Rituximab, Gemcitabine, and Oxaliplatin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Results From the Phase III, Randomized POLARGO Trial
- Update of the decision-making algorithm on selecting transfusion-dependent β-thalassemic patients for gene therapy approaches: joint consensus report on behalf of EHA-specialized working group and EBMT hemoglobinopathies working party
Looking for earlier issues? Visit the News of the Week Archive.